References
- Anil Kumar KS, Misra A, Siddiqi TI, et al. (2014). Synthesis and identification of chiral aminomethylpiperidine carboxamides as inhibitor of collagen induced platelet activation. Eur J Med Chem 81C:456–72
- Brown R, Delp M, Lindstedt S, et al. (1997). Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407–84
- Brunton LL. (2008). Goodman & Gilman’s manual of pharmacology and therapeutics. New York: Mcgraw-Hill
- Choudhry NK, Desai NR. (2012). Aggregating the evidence on antiplatelet drugs: a review of recent clinical trials
- Das P, Oliphant CS, Beach E, Thapa R. (2010). Emerging antiplatelet agents, differential pharmacology, and clinical utility. J Blood Med 1:79–91
- Dikshit DKD, Madhu Siddiqi I, Tanveer, et al. (2013). Chiral 1-(4-methylphenylmethyl)-5-oxo-{N-[(3-T-butoxycarbonyl-aminomethyl)] piperidin-1-Yl}-pyrrolidine-2-carboxamides as inhibitors of collagen induced platelet activation and adhesion. WO/2012/104866
- FDA U. (2001). Guidelines for industry: bioanalytical method validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation And Research Center (CDER) 2001. Available from: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf [last accessed 4 May 2014]
- Hansen ML, Sørensen R, Clausen MT, et al. (2010). Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 170:1433–41
- Ji X, Hou M. (2011). Novel agents for anti-platelet therapy. J Hematol Oncol 4:44 (1–7)
- Joseph JE, Machin SJ. (1997). New antiplatelet drugs. Blood Rev 11:178–90
- Masters S, Trevor A. (2009, Chapter 34). Basic and clinical pharmacology. New York: McGraw-Hill Medical
- Roger VL, Go AS, Lloyd-Jones DM, et al. (2012a). Executive summary: heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation 125:188–97
- Roger VL, Go AS, Lloyd-Jones DM, et al. (2012b). Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation 125:e2–220
- Testa L, Biondi Zoccai GG, Valgimigli M, et al. (2010). Current concepts on antiplatelet therapy: focus on the novel thienopyridine and non-thienopyridine agents. Adv Hematol 2010:595934
- Yeung J, Holinstat M. (2012a). Newer agents in antiplatelet therapy: a review. J Blood Med 3:33–42
- Yeung J, Holinstat M. (2012b). Newer agents in antiplatelet therapy: a review. J Blood Med 3:33–42